Patents by Inventor Patrice Arpin

Patrice Arpin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7009073
    Abstract: A method for preparing indan-1,3-dicarboxylic acid compounds which are useful intermediates in the syntheses of aryl fused azapolycyclic compounds as agents for the treatment of neurological and psychological disorders.
    Type: Grant
    Filed: November 12, 2003
    Date of Patent: March 7, 2006
    Assignee: Pfizer Inc
    Inventors: Timothy J. N. Watson, Mark Christopher Guzman, Patrice Arpin
  • Publication number: 20050240057
    Abstract: A method for preparing indan-1,3-dicarboxylic acid compounds which are useful intermediates in the syntheses of aryl fused azapolycyclic compounds as agents for the treatment of neurological and psychological disorders.
    Type: Application
    Filed: November 12, 2003
    Publication date: October 27, 2005
    Inventors: Timothy Watson, Mark Guzman, Patrice Arpin
  • Patent number: 6686507
    Abstract: A process for the purification of 2-methoxy-5-trifluoro-methoxy benzaldehyde oil in which the oil is converted to amine by reaction of a nitroaniline with the oil; the imine is isolated as a solid; and the solid imine is converted back to the 2-methoxy-5-trifluoromethoxy benzaldehyde oil. The nitroaniline is selected from the group consisting of 3-nitroaniline, 3-methyl-2-nitroaniline, 4-methyl-2-nitroaniline, 2 methyl-3-nitroaniline and 4-methyl-3-nitroaniline.
    Type: Grant
    Filed: December 9, 2002
    Date of Patent: February 3, 2004
    Assignee: Pfizer Inc
    Inventors: Timothy J. N. Watson, Patrice Arpin, Michael G. Vetelino
  • Publication number: 20030176741
    Abstract: A process for the purification of 2-methoxy-5-trifluoro-methoxy benzaldehyde oil in which the oil is converted to amine by reaction of a nitroaniline with the oil; the imine is isolated as a solid; and the solid imine is converted back to the 2-methoxy-5-trifluoromethoxy benzaldehyde oil. The nitroaniline is selected from the group consisting of 3-nitroaniline, 3-methyl-2-nitroaniline, 4-methyl-2-nitroaniline, 2 methyl-3-nitroaniline and 4-methyl-3-nitroaniline.
    Type: Application
    Filed: December 9, 2002
    Publication date: September 18, 2003
    Applicant: Pfizer Inc.
    Inventors: Timothy J. N. Watson, Patrice Arpin, Michael G. Vetelino